The prostaglandin E1 analog misoprostol is widely used to prevent postpartum hemorrhage, which is the leading cause of maternal death in India. Misoprostol is especially practical in low-resource settings because of its efficacy, cost-effectiveness, and ease of administration (sublingual, oral, vaginal, or rectal). It’s also not heat labile, which makes…
Read more »
Approximately one-quarter of all pregnancy- and delivery-related maternal deaths worldwide occur in India, most of which are caused by postpartum hemorrhage, according to the World Health Organization (WHO). WHO recommends Active Management of the Third Stage of Labor (AMTSL), which includes several components: Key Point: Controlled cord traction is not…
Read more »
Postpartum hemorrhage is the leading cause of maternal death in India. The majority of these cases are preventable, but due to a lack of resources in many settings, maternal death rates in India remain higher than in other developing countries. The national maternal mortality rate in India is 254 per…
Read more »
indicates a Peer-Reviewed Article
Using Misoprostol for Primary versus Secondary Prevention of Postpartum Haemorrhage – Do Costs Matter?
Postpartum Haemorrhage (PPH) is commonly defined as a blood loss of 500 ml or more within 24 hours after birth. PPH is the leading cause of maternal mortality in low and middle-income countries and the primary…
Read more »